Wordt geladen...
Type II CRISPR/Cas9 approach in the oncological therapy
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a prokaryotic adaptable immune mechanism used by many bacteria and archaea to protect themselves from foreign nucleic acids. This complex system can recognize and cut non-self DNA in order to provide the prokaryotic organisms a st...
Bewaard in:
| Gepubliceerd in: | J Exp Clin Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5472952/ https://ncbi.nlm.nih.gov/pubmed/28619109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0550-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|